Search bioRxiv⌕ Search

Biology subjects

Jitender,

Publications and source records attributed to Jitender,.

2 recordsLinked to original sources

Molecular plasticity in the flavin binding pocket of BLUF domain evolves first light-gated endonuclease in bacterial system

The bacterium Rubellimicrobium mesophilum possesses a BLUF coupled endonuclease III (BLUF-EndoIII) with potential endonuclease activity. Interestingly, the crucial amino acid residues (tyrosine, histidine and tryptophan) responsible for BLUF photocycle and photodynamics are evolutionarily replaced by phenylalanine (Y5F), asparagine (H27N) and alanine (W87A) residues, respectively. In present communication, we have studied the impact of this evolutionary plasticity on the BLUF photodynamics and associated endonuclease activity. The results obtained showed that the evolutionary plasticity in the BLUF domain influenced various functional aspects of BLUF domain including FAD binding, domain stability, recovery kinetics, and spectral characteristics. The impact of amino acid plasticity on the C-terminal endonuclease (EndoIII) domain was also studied. The evolutionary plasticity induced changes in the flavin binding pocket of the BLUF domain elevated the light-gated endonuclease activity associated with EndoIII domain. The molecular docking analysis and spectroscopic studies also confirmed the substrate-binding ability of the BLUF-EndoIII. The elevated endonuclease activity suggested that the amino acid residues, which are crucial for BLUF photocycle are indeed dispensable and there might exists another electron transfer pathway for BLUF domain activation and regulation of associated endonuclease domain. Considering the role of endonucleases in bacterial defense, the understanding of the BLUF photodynamics, mechanism of signal transfer to the downstream endonuclease domain and associated endonuclease activity might elucidate the first naturally occurring light-gated endonuclease in bacterial system.

biochemistry↗

A broadly protective CHO cell expressed recombinant spike protein subunit based vaccine (IMT-CVAX) against SARS-CoV-2

Protective immunity induced by COVID-19 vaccines is mediated mainly by spike (S) protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Here, we report the development of a recombinant prefusion stabilized SARS-CoV-2 spike protein-subunit-based COVID-19 vaccine produced in the mammalian cell line. The gene encoding ectodomain (ECD) of the spike protein was engineered and cloned into Freedom pCHO 1.0, a mammalian expression vector, and subsequently expressed in the Chinese Hamster Ovary suspension cell line (CHO-S). The recombinant S protein ectodomain (hereafter referred to as IMT-CVAX) was purified using a combination of tangential flow filtration and liquid chromatography. Biochemical and biophysical characterization of IMT-CVAX was done to ensure its vital quality attributes. Intramuscular immunization of mice with two doses of adjuvanted IMT-CVAX elicited a strong anti-Spike IgG response. In pseudovirus-based assays, IMT-CVAX- immune mice sera exhibited a broad-spectrum neutralization of several SARS-CoV-2 variants of concern (VoCs). Golden Syrian Hamster immunized with IMT-CVAX provided excellent protection against SARS-CoV-2 infection, and, hamster immune sera neutralized the live SARS-CoV-2 virus. The adjuvanted IMT-CVAX induced robust Tfh-cells response and germinal center (GC) reaction in human ACE2 receptor-expressing transgenic mice. The findings of this study may pave the way for developing next-generation protein subunit-based vaccines to combat the existing SARS-CoV-2 and its emerging VoCs. The IMT-CVAX is produced using a scalable process and can be used for large-scale vaccine production in an industrial setup.

microbiology↗